Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ISR

Isoray (ISR) Stock Price, News & Analysis

Isoray logo

About Isoray Stock (NYSE:ISR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.28
$0.42
52-Week Range
N/A
Volume
145,000 shs
Average Volume
290,697 shs
Market Capitalization
$54.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISR Stock News Headlines

French ISR Label Revamp Report
Why IsoRay (ISR) Is Plunging Today
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
Why IsoRay (ISR) Stock Is Surging Today
IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates
See More Headlines

ISR Stock Analysis - Frequently Asked Questions

Isoray, Inc. (NYSE:ISR) posted its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The business had revenue of $2.56 million for the quarter, compared to the consensus estimate of $2.58 million. Isoray had a negative trailing twelve-month return on equity of 17.12% and a negative net margin of 115.91%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Isoray investors own include Brainstorm Cell Therapeutics (BCLI), OPKO Health (OPK), Tesla (TSLA), Meta Platforms (META), Tonix Pharmaceuticals (TNXP) and Nano Dimension (NNDM).

Company Calendar

Last Earnings
11/10/2021
Today
9/03/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NYSE:ISR
CIK
728387
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.27 million
Net Margins
-115.91%
Pretax Margin
-91.45%
Return on Equity
-17.12%
Return on Assets
-16.15%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.38
Quick Ratio
13.99

Sales & Book Value

Annual Sales
$10.80 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.43 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
142,110,000
Free Float
138,674,000
Market Cap
$54.57 million
Optionable
Not Optionable
Beta
1.48

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:ISR) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners